Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
INR 1,824.00
(+0.84%)
Based on the Sun Pharmaceutical Industries Limited stock forecast from 3 analysts, the average analyst target price for Sun Pharmaceutical Industries Limited is INR 1,824.00 over the next 12 months. Sun Pharmaceutical Industries Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Sun Pharmaceutical Industries Limited is Bullish , which is based on 4 positive signals and 1 negative signals. At the last closing, Sun Pharmaceutical Industries Limited’s stock price was INR 1,808.85. Sun Pharmaceutical Industries Limited’s stock price has changed by -0.25% over the past week, +1.62% over the past month and +46.64% over the last year.
No recent analyst target price found for Sun Pharmaceutical Industries Limited
No recent average analyst rating found for Sun Pharmaceutical Industries Limited
Company Overview Sun Pharmaceutical Industries Limited
N/A
N/A
N/A
N/A
INR
India
Adjusted Closing Price for Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE)
Loading...
Unadjusted Closing Price for Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE)
Loading...
Share Trading Volume for Sun Pharmaceutical Industries Limited Shares
Loading...
Compare Performance of Sun Pharmaceutical Industries Limited Shares
Frequently Asked Questions About Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE) Stock
Based on ratings from 3 analysts Sun Pharmaceutical Industries Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 2 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on SUNPHARMA:NSE's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for SUNPHARMA:NSE is INR 1,824.00 over the next 12 months. The maximum analyst target price is INR 1845 while the minimum anlayst target price is INR 1800.
Unfortunately we do not have enough data on SUNPHARMA:NSE's stock to indicate if its overvalued.
The last closing price of SUNPHARMA:NSE's stock was INR 1,808.85.
Unfortunately we do not currently have any market capitalization data for SUNPHARMA:NSE's stock.
Based on targets from 3 analysts, the average taret price for SUNPHARMA:NSE is projected at INR 1,824.00 over the next 12 months.
This means that SUNPHARMA:NSE's stock price may go up by +0.84% over the next 12 months.
We can't find any ETFs which contains Sun Pharmaceutical Industries Limited's stock.
Sorry, we do not have any data on the number of employees for Sun Pharmaceutical Industries Limited.
Sorry we do not have any infomation available on Sun Pharmaceutical Industries Limited's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Frequently Asked Questions About Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE) Stock
Based on ratings from 3 analysts Sun Pharmaceutical Industries Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 2 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on SUNPHARMA:NSE's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for SUNPHARMA:NSE is INR 1,824.00 over the next 12 months. The maximum analyst target price is INR 1845 while the minimum anlayst target price is INR 1800.
Unfortunately we do not have enough data on SUNPHARMA:NSE's stock to indicate if its overvalued.
The last closing price of SUNPHARMA:NSE's stock was INR 1,808.85.
Unfortunately we do not currently have any market capitalization data for SUNPHARMA:NSE's stock.
Based on targets from 3 analysts, the average taret price for SUNPHARMA:NSE is projected at INR 1,824.00 over the next 12 months.
This means that SUNPHARMA:NSE's stock price may go up by +0.84% over the next 12 months.
We can't find any ETFs which contains Sun Pharmaceutical Industries Limited's stock.
Sorry, we do not have any data on the number of employees for Sun Pharmaceutical Industries Limited.
Sorry we do not have any infomation available on Sun Pharmaceutical Industries Limited's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SUNPHARMA:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
